NCT04529434

Brief Summary

Malaria, pneumonia and diarrhoea causes a lot of illness in children in Tanzania and the study want to find better ways of protecting people against these diseases and want to find out if the type of house design can affect the general health of children living in the house.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,183

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2020

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 27, 2020

Completed
1.4 years until next milestone

Study Start

First participant enrolled

January 4, 2022

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

4 years

First QC Date

August 6, 2020

Last Update Submit

April 28, 2026

Conditions

Keywords

Healthy housesTanzania

Outcome Measures

Primary Outcomes (3)

  • Incidence of malaria in children under 13 years of age.

    The incidence per year of malaria in children under 13 years old.

    Approximately 3 years

  • Incidence of respiratory tract disease in children under 13 years of age.

    The incidence per year of respiratory tract disease in children under 13 years old.

    Approximately 3 years

  • Incidence of diarrhoeal disease in children under 13 years of age.

    The incidence per year of diarrhoeal disease in children under 13 years old.

    Approximately 3 years

Secondary Outcomes (20)

  • Mean number of female An. gambiae s.l.

    Approximately 3 years

  • Mean number of flies

    Approximately 3 years

  • Entomological inoculation rate of malaria vectors.

    Approximately 3 years

  • Children requiring hospital admission

    Approximately 3 years

  • Major respiratory pathogens

    Approximately 3 years

  • +15 more secondary outcomes

Study Arms (2)

Arm 1

EXPERIMENTAL

Households living in novel-design houses.

Other: Star Homes

Arm 2

OTHER

Households living in traditional African houses.

Other: Traditional African houses

Interventions

110 identical novel-designed houses, known as Star Homes, include the critical structural components e.g. building orientated to provide optimal shading throughout the day, light-weight \& durable roof, facade and openings screened from insects to reduce insect entry while assuring airflow, an outdoor fly-proof latrine, and solar power providing electric light at night etc.

Arm 1

A traditional mud house: with wattle and daub walls, a thatched roof, and no electricity or piped water supply.

Arm 2

Eligibility Criteria

AgeUp to 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Main study
  • Children, aged under 13 years old, male or female
  • Residing in a study village for at least 3 years
  • Parents/guardian is willing and able to give written informed consent for the child to participate in the baseline and end-of study evaluation and the surveillance for malaria, respiratory tract infection and diarrhoeal disease.
  • Additionally, children 10, 11, and 12 years of age provide assent to participate.
  • Ancillary studies
  • Head of a household or other family member of a household that is taking part in the main study
  • years and above
  • Consent to take part in the main study
  • Residing and live in the village for 3 years or more
  • Live in the intervention or comparison houses or a trusted community member (community leaders, medical officer and community health worker)

You may not qualify if:

  • Main study
  • Any participant who refuses, or in the case of children whose parents/guardian refuses, to participate in the study.
  • Any child who is between 10 and 12 years who refuses to provide assent
  • If the family plans for moving to other village during the study period
  • Parents/guardians have mental health problems
  • Ancillary studies
  • Under 18 years
  • Not provide consent
  • Not living in the study village for 3 years or more

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CSK Research Solutions

Dar Es Salaam, Mtwara, Tanzania

Location

Related Publications (3)

  • Mshamu S, Mukaka M, Sanga C, Kambanga S, Rutaihwa AD, Bojstrup TC, Meta J, Mmbando A, Pell C, Adhikari B, Olotu AI, Kapologwe N, White NJ, Dondorp AM, Day NPJ, Imwong M, Deen J, Lindsay SW, Knudsen JB, von Seidlein L. A sustainable house design to improve child health in rural Africa: a cluster-randomized controlled trial. Nat Med. 2026 Apr 21. doi: 10.1038/s41591-026-04367-w. Online ahead of print.

  • Mmbando AS, Ngonzi AJ, Mshamu S, Bradley J, Bojstrup TC, Ngowo HS, Knudsen J, von Seidlein L, Okumu FO, Lindsay SW. Effect of a novel house design (star home) on indoor malaria mosquito abundance in rural Tanzania: secondary outcomes of an open-label, household, randomised controlled trial. Lancet Planet Health. 2025 Apr;9(4):e253-e263. doi: 10.1016/S2542-5196(25)00046-4.

  • Mshamu S, Mmbando A, Meta J, Bradley J, Bojstrup TC, Day NPJ, Mukaka M, Okumu F, Olotu A, Pell C, Deen J, Knudsen J, Lindsay SW, von Seidlein L. Assessing the impact of a novel house design on the incidence of malaria in children in rural Africa: study protocol for a household-cluster randomized controlled superiority trial. Trials. 2022 Jun 20;23(1):519. doi: 10.1186/s13063-022-06461-z.

MeSH Terms

Conditions

Malaria

Condition Hierarchy (Ancestors)

Protozoan InfectionsParasitic DiseasesInfectionsMosquito-Borne DiseasesVector Borne Diseases

Study Officials

  • Lorenz von Seidlein, Ass.Prof.

    Mahidol Oxford Tropical Medicine Research Unit

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This is an open-label household randomised controlled trial that will compare the 110 novel-design houses with 440 traditional African homes.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 6, 2020

First Posted

August 27, 2020

Study Start

January 4, 2022

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Data collected for this study will be under the custodianship of MORU. With participant's consent, data from this study may be shared in a de-identified form with other groups or researchers in accordance with the MORU Data Sharing Policy.

Time Frame
After completion of trial activities and reporting
Access Criteria
MORU Data Sharing Policy. (http://www.tropmedres.ac/data-sharing-policy)

Locations